Literature DB >> 17578775

Long-term outcomes of 217 botulism cases in the Republic of Georgia.

Sami L Gottlieb1, Katrina Kretsinger, Nato Tarkhashvili, Neli Chakvetadze, Maia Chokheli, Marina Chubinidze, R Michael Hoekstra, Ekaterina Jhorjholiani, Merab Mirtskhulava, Maia Moistsrapishvili, Merab Sikharulidze, Tamar Zardiashvili, Paata Imnadze, Jeremy Sobel.   

Abstract

BACKGROUND: The acute paralytic syndrome of botulism has been well-described; however, little is known about its long-term consequences.
METHODS: We conducted a case-control study in the Republic of Georgia to evaluate the health of patients > or =6 months after they had experienced an episode of botulism. Case patients were selected on the basis of who had had a clinical diagnosis of foodborne botulism reported to the national surveillance system from 1998 through 2003. Three control subjects were randomly selected from each patient's community.
RESULTS: We located 217 patients who had had botulism from surveillance records, with a median time since onset of illness of 4.3 years. The median age was 37 years, and 49% of the patients were female, similar to the control subjects. Most of the patients (68%) had acquired botulism from home-conserved vegetables (probably containing toxin type B), 15% had been hospitalized for >1 month, and 25% had required mechanical ventilation. Six patients died. Of the remaining 211 patients, 68% reported having worse health at the time of the interview than 6 years before the interview, compared with 17% of 656 control subjects (matched odds ratio, 17.6; 95% confidence interval, 10.9-28.4). Overall, 49% of the patients reported their current health as "fair" or "poor," versus 25% of the control subjects (odds ratio, 5.0; 95% confidence interval, 3.2-7.6). Patients were more likely than control subjects to report fatigue, weakness, dizziness, dry mouth, and difficulty lifting objects (P<.05, for each). Patients were more likely than control subjects to report difficulty breathing caused by moderate exertion (P<.001) but not by minimal exertion or at rest. Patients were also more likely to report being limited in vigorous activities, walking 3 blocks, and climbing 3 flights of stairs (P<.05, for each). Finally, patients reported feeling significantly worse than control subjects for 6 of 11 questions regarding psychosocial well-being (P<.05, for each). In a multivariable model involving patients who had had botulism, mechanical ventilation during acute illness, older age, and region of residence independently predicted worse health.
CONCLUSIONS: Several years after acute botulism, patients reported significant health, functional, and psychosocial limitations that are likely to be consequences of the illness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578775     DOI: 10.1086/518890

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Symptomatic treatment of botulism with a clinically approved small molecule.

Authors:  Edwin Vazquez-Cintron; James Machamer; Celinia Ondeck; Kathleen Pagarigan; Brittany Winner; Paige Bodner; Kyle Kelly; M Ross Pennington; Patrick McNutt
Journal:  JCI Insight       Date:  2020-01-30

2.  Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridine.

Authors:  James B Machamer; Edwin J Vazquez-Cintron; Sean W O'Brien; Kyle E Kelly; Amber C Altvater; Kathleen T Pagarigan; Parker B Dubee; Celinia A Ondeck; Patrick M McNutt
Journal:  Mol Med       Date:  2022-06-03       Impact factor: 6.376

3.  Quantitative autonomic testing in the management of botulism.

Authors:  Raffi Topakian; Christoph Heibl; Karl Stieglbauer; Bettina Dreer; Markus Nagl; Peter Knoflach; Franz Thaddäus Aichner
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

4.  BOTOX injection to treat strabismus after infant botulism type B infection.

Authors:  Sarah G Bonaffini; Victoria Cocozza; Jing Jin
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.